APHP - Hôpital Necker
Also known as: APHP - Centre Hospitalier Universitaire Necker | AP-HP - Department of Pediatric Gastroenterology Hepatology and Nutrition - Necker - Enfants Malades Hospital | APHP - Hôpital Necker | APHP Necker | AP-HP - Service médecine interne | Centre de référence maladies auto-immunes et systémiques rares, Internal medicine, Cochin hospital, APHP | Département de Biothérapie : Hôpital Necker Enfants malades | Department of Biotherapy,LTCG, Necker-Enfants Malades Hospital | Hôpital Lariboisière, Paris (AP-HP) | Hôpital Necker | Hôpital Pitié Salpêtrière - Assitance Publique Hôpitaux de Paris | Hôpital Pitié-Salpêtrière - Assitance Publique - Hôpitaux de Paris | Hospital Necker, Department of haematology and immunology | Hospital Necker Enfants Malades | Medical Intensive Care Unit, Ambroise Paré Hospital, APHP | Medical Intensive Care Unit, Cochin Hospital, APHP | Pr Isabelle CONSTANT | Reference Centre for Mastocytosis (CEREMAST), Necker Hospital, Paris, France | URC Necker Cochin | Virology laboratory- reference national Lab for CMV infection -Hôpital Necker-Enfants malades, Paris
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2006Last known activity
Mar 31, 2023
Timeline
1770s
- Jan 1, 1778
APHP - Hôpital Necker— Founded
Drugs by trial phase (35 distinct, 20 trials)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Coronavirus Infections
- Hemorrhage
- Immunoblastic Lymphadenopathy
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Mastocytosis
- Mastocytosis, Systemic
- Osteoporosis
- Pulmonary Alveolar Proteinosis
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Severe Acute Respiratory Syndrome
- Subarachnoid Hemorrhage
- Syndrome
Recent trials (21)
- NCT05202990Overall official - principal investigatorPhase 2Mar 31, 2023
- NCT05446571Study chairPhase 3Dec 31, 2022
- NCT05449444Overall official - principal investigatorPhase 2Jul 1, 2022
- NCT05071222Study directorPhase 1/Phase 2Oct 31, 2021
- NCT04707300Study directorPhase 1/Phase 2Oct 31, 2021
- NCT04871191Study directorPhase 2Sep 30, 2021
- NCT04732260Study chairN/AJun 11, 2021
- NCT04702256Overall official - principal investigatorPhase 3Apr 30, 2021
- NCT04591990Overall official - principal investigatorPhase 3Nov 30, 2020
- NCT04591990Study directorPhase 3Nov 30, 2020
- NCT04362527Overall official - principal investigatorPhase 3Apr 30, 2020
- NCT04333368Overall official - principal investigatorPhase 1/Phase 2Apr 1, 2020
- NCT03894657Overall official - principal investigatorN/AApr 30, 2019
- NCT03887169Overall official - principal investigatorPhase 1/Phase 2Apr 30, 2019
- NCT03593018Study chairPhase 3Sep 30, 2018
Details
- Founded
- Paris, FR Jan 1, 1778
- Last known activity
- Mar 31, 2023